- Research works
- 27 ▲ 345% vs 2013–17
- Citations
- 187 6.9 per fractional work
- Top-10% rate
- 17.7% record average 16.5%
- Open access
- 12% world 28%
Not ranked overall: Acura Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.9×. Every wedge is a field page.
Which keywords describe research at Acura Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Colonialism, Literature, Management, Risk Assessment, Social Acceptance, Healthcare and Assurance Cases.
- Safety Assurance
- Private R&D
- Medical Equipment
- History
- Disabilities
- Assurance Cases
- Risk Assessment
- Healthcare
- Literature
- Colonialism
- Epidemiology
- Globalization
- Management
- Machine Learning
- Social Acceptance
- Attitudes
- Gender
- Maintenance
- Nationalism
- R&D Subsidies
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 20 words, with their numbers
- Epidemiology3▲ 2.6×13 topics
- Colonialism2▲ 11×2 topics
- Globalization2▲ 3.0×4 topics
- Literature2▲ 11×2 topics
- Management1▲ 6.5×4 topics
- Healthcare1▲ 6.0×2 topics
- Machine Learning1▲ 1.98×2 topics
- Risk Assessment1▲ 7.7×3 topics
- Social Acceptance1▲ 200×2 topics
- Assurance Cases1▲ 497×1 topic
- Attitudes1▲ 118×1 topic
- Disabilities1▲ 373×1 topic
- Gender1▲ 6.4×1 topic
- History1▲ 4.6×1 topic
- Maintenance1▲ 54×1 topic
- Medical Equipment1▲ 145×1 topic
- Nationalism1▲ 6.4×2 topics
- Private R&D1▲ 217×1 topic
- R&D Subsidies1▲ 217×1 topic
- Safety Assurance1▲ 497×1 topic
Which research topics does Acura Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Virus-based gene therapy research, Cancer Research and Treatments, RNA Interference and Gene Delivery and Electrospun Nanofibers in Biomedical Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Virus-based gene therapy research Genetics 0 works
- 2 Cancer Research and Treatments Biotechnology 0 works
- 3 RNA Interference and Gene Delivery Molecular Biology 0 works
- 4 Electrospun Nanofibers in Biomedical Applications Biomaterials 0 works
- 5 Child Nutrition and Feeding Issues Psychiatry and Mental health 0 works
- 6 Dysphagia Assessment and Management Speech and Hearing 0 works
- 7 Mesenchymal stem cell research Genetics 0 works
- 8 Tissue Engineering and Regenerative Medicine Surgery 0 works
- 9 Expert finding and Q&A systems Information Systems 0 works
- 10 Cardiovascular Health and Risk Factors Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Acura Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 345% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Palatine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.